These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27859430)

  • 1. High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits.
    Eshraghian A
    Hepatology; 2017 Mar; 65(3):1077. PubMed ID: 27859430
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case-Control Study.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Fragopoulou E; Ioannidou P; Papageorgiou M; Alexopoulou A; Papadopoulos N; Deutsch M; Kontogianni MD
    Metab Syndr Relat Disord; 2017 Mar; 15(2):72-79. PubMed ID: 27869531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.
    Shi L; Liu ZW; Li Y; Gong C; Zhang H; Song LJ; Huang CY; Li M
    Biomed Environ Sci; 2012 Aug; 25(4):383-91. PubMed ID: 23026517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonobese Fatty Liver Disease.
    Kim D; Kim WR
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):474-485. PubMed ID: 27581063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors.
    Al-Dayyat HM; Rayyan YM; Tayyem RF
    Diabetes Metab Syndr; 2018 Jul; 12(4):569-575. PubMed ID: 29571977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating the patient with nonalcoholic fatty liver disease.
    Chaney A
    Nurse Pract; 2015 Nov; 40(11):36-42; quiz 42-3. PubMed ID: 26474202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and Lifestyle in Nonalcoholic Fatty Liver Disease.
    Martínez-Beamonte R; Acín S; Ramírez-Torres A; Ángeles Navarro M
    Can J Gastroenterol Hepatol; 2020; 2020():3495082. PubMed ID: 33489993
    [No Abstract]   [Full Text] [Related]  

  • 11. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.
    Della Pepa G; Vetrani C; Lombardi G; Bozzetto L; Annuzzi G; Rivellese AA
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28954437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle Modifications.
    Nguyen V; George J
    Semin Liver Dis; 2015 Aug; 35(3):318-37. PubMed ID: 26378647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease and the Need for Action.
    Sporea I; Sirli R
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):139-141. PubMed ID: 32530977
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Younossi ZM; Henry L; Bush H; Mishra A
    Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation?
    Naderian M; Ebrahimi H; Sohrabpour AA
    Hepatology; 2016 Oct; 64(4):1390-1. PubMed ID: 27045003
    [No Abstract]   [Full Text] [Related]  

  • 16. Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease.
    Fleet SE; Lefkowitch JH; Lavine JE
    Gastroenterol Clin North Am; 2017 Jun; 46(2):217-231. PubMed ID: 28506362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.
    Andronescu CI; Purcarea MR; Babes PA
    J Med Life; 2018; 11(1):20-23. PubMed ID: 29696060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of nonalcoholic fatty liver disease in Asia].
    Zhang W; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):801-4. PubMed ID: 24516923
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.
    Milic S; Mikolasevic I; Krznaric-Zrnic I; Stanic M; Poropat G; Stimac D; Vlahovic-Palcevski V; Orlic L
    Drug Des Devel Ther; 2015; 9():4835-45. PubMed ID: 26316717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].
    Xing A; Ji C; Shi J; Du X; Huang Z; Lin L; Xiong H; Wu S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jan; 36(1):40-4. PubMed ID: 25876863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.